Capture of systemic anticancer medicines in Pharmaceutical Benefits Scheme (PBS) data likely higher than previously reported - Authors' reply.

Creighton, N Torvonen, HE Zhao, GW Currow, DC

Permalink

Open Access

Copyright Clearance Process

This item is open access.

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Creighton, N
dc.contributor.author	Torvonen, HE
dc.contributor.author	Zhao, GW
dc.contributor.author	Currow, DC
dc.date.accessioned	2020-08-06T01:16:21Z
dc.date.available	2020-08-06T01:16:21Z
dc.date.issued	2020-06-30
dc.identifier.citation	Public health research & practice, 2020, 30, (2)
dc.identifier.issn	2204-2091
dc.identifier.issn	2204-2091
dc.identifier.uri	http://hdl.handle.net/10453/141980
dc.format	Electronic
dc.language	eng
dc.publisher	The Sax Institute
dc.relation.ispartof	Public health research & practice
dc.relation.isbasedon	10.17061/phrp3022014
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1117 Public Health and Health Services
dc.title	Capture of systemic anticancer medicines in Pharmaceutical Benefits Scheme (PBS) data likely higher than previously reported - Authors' reply.
dc.type	Journal Article
utslib.citation.volume	30
utslib.location.activity	Australia
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
pubs.organisational-group	/University of Technology Sydney
utslib.copyright.status	open_access	*
pubs.consider-herdc	false
dc.date.updated	2020-08-06T01:16:17Z
pubs.issue	2
pubs.publication-status	Published
pubs.volume	30
utslib.citation.issue	2

Please use this identifier to cite or link to this item: